Browse Category

Biotechnology 25 June 2026 - 23 July 2026

Thermo Fisher (NYSE:TMO) shares gain as instrument margins exceed sales growth

Shares of Thermo Fisher Scientific Inc. rose roughly 10% on Thursday after the company topped quarterly expectations and increased its profit outlook. U.S. cash markets were open. As of 9:52 a.m. EDT, the stock was trading at $578.85, according to initial intraday figures.

23 July 2026

Biotechnology·NYSE:TMO·Stock Market

Advanced Biomed Inc. (NASDAQ:ADVB) jumps as $25 million equity facility concludes

Shares of Advanced Biomed Inc. climbed 74.6% to $12.36 on Wednesday after the company ended a $25 million equity line. A connected share-registration filing was retracted as well. Trading on Nasdaq continued at 15:10 EDT.

22 July 2026

Biotechnology·Nasdaq·NASDAQ:ADVB·Stock Market

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations

Shares of InMed Pharmaceuticals Inc. climbed 21% to $1.87 during late-morning trading on the Nasdaq. Mentari Therapeutics, which is merging with InMed, revealed a $200 million private placement.

22 July 2026

Biotechnology·NASDAQ:INM·Pharmaceuticals·Stock Market

Jupiter Neurosciences (NASDAQ:JUNS) surge cools as $100 million MDMA agreement strains funding resources

Jupiter Neurosciences shares gave up much of an earlier 67% rally on Tuesday after securing U.S. rights for a trial-stage MDMA drug. The stock was up 6.2% at $0.1752 as of 12:50 p.m. EDT.

21 July 2026

Biotechnology·CNSX:MDMA·NASDAQ:JUNS·Pharmaceutical Industry·Stock Market

Tetratherix trades lightly as it holds A$358 million valuation

Tetratherix Ltd finished Friday with a market capitalization of A$358.0 million. Out of a total 53.04 million ordinary shares, only 29.47 million are listed.

20 July 2026

ASX:TTX·Biotechnology·Stock Market

AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face

AtaiBeckley, previously known as Atai Life Sciences, closed at $7.22 on Friday, trading 47 cents higher than the cash element of Eli Lilly’s offer. U.S. stock markets did not open on Sunday.

19 July 2026

Biotechnology·NASDAQ:ATAI·NYSE:LLY·Stock Market

ImmunityBio (NASDAQ:IBRX) stock faces July 24 warrant-expiry test after Friday rebound

ImmunityBio, Inc. enters next week with a warrant-expiry test. Up to 6.4 million new shares could emerge on Friday. That figure uses the March 31 balance.

18 July 2026

Biotechnology·NASDAQ:IBRX·Stock Market

CSL Limited (ASX:CSL) awaits US$650 million hurdle ahead of August results, pressuring rebound

CSL Limited gained 1.12% to close at A$123.32 on Friday. The S&P/ASX 200 index slipped 0.50%. Sydney’s cash market remained closed on Saturday morning.

18 July 2026

ASX News·ASX:CSL·Biotechnology·Earnings Reports·Stock Market

VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base

VivoSim Labs, Inc. reported Wednesday it got a $5 million milestone payment from Eli Lilly and Company, bringing in cash worth about 1.7 times VivoSim’s equity value at Tuesday’s close and recent share count. Still, shares ended up just 3.0% at $0.8599, slipping from an open of $1.49.

15 July 2026

Biotechnology·Nasdaq·NASDAQ:VIVS·NYSE:LLY·Stock Market

AtaiBeckley Inc. (NASDAQ:ATAI) stock jumps as FDA staffing guidance spotlights BPL-003’s two-hour edge

AtaiBeckley Inc. shares climbed 15.6% to about $5.75 in Tuesday afternoon trading as investors weighed final U.S. Food and Drug Administration guidance for psychedelic-drug trials. The document expects two monitors to remain with a patient throughout a treatment session, making BPL-003’s roughly two-hour clinic model more relevant to operating costs. Duration is now a cost variable.

14 July 2026

Biotechnology·NASDAQ:ATAI·Stock Market

NextCure stock surge puts cash payout and 1.21% Avere stake under the lens

NextCure, Inc. shares nearly tripled on Tuesday after the cancer-drug developer agreed to merge with privately held Avere Therapeutics and pair the transaction with a $320 million financing. Yet current holders are expected to own just 1.21% of the combined company, making the rally a wager on a possible cash distribution, a contingent-value right and a higher public valuation for Avere—not merely the financing headline.

14 July 2026

Biotechnology·NASDAQ:NXTC·Stock Market

Virax Biolabs (NASDAQ:VRAX) Soars 183% After Fosun Deal

Virax Biolabs Group shares jumped more than 100% during Thursday’s U.S. session after the diagnostics company said its UK subsidiary reached an exclusive multi-country supply deal with Fosun Diagnostics for its ImmuneSelect research-use immune-profiling line. The Nasdaq stock was trading at $9.00 as of 11:52 a.m. EDT, up $5.82 on the day, with about 57.8 million shares changing hands.

9 July 2026

Biotechnology·NASDAQ:VRAX·Stock Market

Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn

Bluejay Diagnostics, Inc. jumped before the open on Tuesday. The rally put a tiny diagnostics stock back on active trader screens, but the sharper point was the financing math sitting above the tape.

7 July 2026

Biotechnology·NASDAQ:BJDX·Stock Market

Recursion Pharmaceuticals (NASDAQ:RXRX) stock gains as short interest and Russell flows hit AI-biotech rally

Nasdaq traded normally at the dateline after being shut July 3 for the Independence Day holiday. Recursion Pharmaceuticals, Inc. rose 4.7% to $3.98 in the latest quote, adding about $95 million in market cap at that price.

6 July 2026

Artificial Intelligence·Biotechnology·Nasdaq·NASDAQ:RXRX·Stock Market

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades

Regencell Bioscience Holdings Limited dropped Thursday morning after jumping on Wednesday. The move came as biotech funds traded higher. The stock is trading out of sync with the sector and is still well under the price from the company’s share sale six weeks back.

2 July 2026

Biotechnology·Nasdaq·NASDAQ:RGC·Stock Market

CELZ jumps before FDA update as traders weigh dilution math

Creative Medical Technology Holdings, Inc. shares surged Tuesday on Nasdaq. The Phoenix biotech pulled an equity-and-warrant registration statement that was big versus its share count.

30 June 2026

Biotechnology·NASDAQ:CELZ

Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Abivax S.A. is set for a lagged Paris opening after its U.S. ADS jumped in after-hours trading. Investors reacted to new clinical data on obefazimod, Abivax’s ulcerative colitis drug. The latest news hits late, but the drop earlier this month wasn’t about whether the drug works. It was about the potential cancer risk and what that could mean for the drug’s label.

30 June 2026

Biotechnology·EPA:ABVX·NASDAQ:ABVX·Stock Market

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna, Inc. jumped 12.59% Friday to close at $67.27, snapping a stretch this week where traders mostly ignored pipeline optionality. The stock started the week at $63.96 and finished up $3.31 for the week. Most of that came Friday, when the shares rose $7.52.

27 June 2026

Biotechnology·NASDAQ:MRNA·Stock Market

SELLAS Life Sciences (NASDAQ:SLS) trades higher after new share count shows nearly $2 billion value

SELLAS Life Sciences Group Inc is up 12.6% at $10.33 in Thursday afternoon action, trading 12.2 million shares. The stock opened at $9.21, hit $11.05, and last traded at $10.33 at 2:51 p.m. EDT. Previous close was $9.17.

25 June 2026

Biotechnology·Nasdaq·NASDAQ:SLS·Stock Market

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

Bio-Techne Corporation moved into merger-arb territory Thursday morning after Germany’s Merck KGaA said it would acquire the life-sciences tools company for $73 per share in cash. Shares traded at $70.17 at 9:51 a.m. EDT, up 19.18%, leaving a $2.83 spread to the offer.

25 June 2026

Biotechnology·NASDAQ:TECH·XETRA:MRK

Previous 1 2 3 4 … 21 Next

Biotechnology 25 June 2026 - 23 July 2026

Thermo Fisher (NYSE:TMO) shares gain as instrument margins exceed sales growth

Advanced Biomed Inc. (NASDAQ:ADVB) jumps as $25 million equity facility concludes

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations

Jupiter Neurosciences (NASDAQ:JUNS) surge cools as $100 million MDMA agreement strains funding resources

Tetratherix trades lightly as it holds A$358 million valuation

AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face

ImmunityBio (NASDAQ:IBRX) stock faces July 24 warrant-expiry test after Friday rebound

CSL Limited (ASX:CSL) awaits US$650 million hurdle ahead of August results, pressuring rebound

VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base

AtaiBeckley Inc. (NASDAQ:ATAI) stock jumps as FDA staffing guidance spotlights BPL-003’s two-hour edge

NextCure stock surge puts cash payout and 1.21% Avere stake under the lens

Virax Biolabs (NASDAQ:VRAX) Soars 183% After Fosun Deal

Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn

Recursion Pharmaceuticals (NASDAQ:RXRX) stock gains as short interest and Russell flows hit AI-biotech rally

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades

CELZ jumps before FDA update as traders weigh dilution math

Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

SELLAS Life Sciences (NASDAQ:SLS) trades higher after new share count shows nearly $2 billion value

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

TechStock² Updates

Oklo (NYSE:OKLO) achieves reactor criticality; $4.2 billion valuation requires commercial validation

Plug Power (NASDAQ:PLUG) Confronts $471 Million Revenue Challenge in Second Half

Nebius Group (NASDAQ:NBIS) gains following $7.4 billion Vineland sale

Electronic Arts closes at $209.70 following $55 billion buyout, attention moves to debt

CLARITY Act delay leaves a two-sided stablecoin trade for crypto stocks

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer